{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T12:54:13Z","timestamp":1773752053087,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02884-x","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T02:39:05Z","timestamp":1751942345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic biomarkers in treatment-na\u00efve central retinal vein occlusion with macular edema"],"prefix":"10.1186","volume":"30","author":[{"given":"Yu","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9159-7972","authenticated-orcid":false,"given":"Shancheng","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"issue":"7","key":"2884_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.18240\/ijo.2023.07.21","volume":"16","author":"Q Xing","year":"2023","unstructured":"Xing Q, Dai YN, Huang XB, Peng L. Comparison of efficacy of conbercept, aflibercept, and ranibizumab ophthalmic injection in the treatment of macular edema caused by retinal vein occlusion: a Meta-analysis. Int J Ophthalmol. 2023;16(7):1145\u201354. https:\/\/doi.org\/10.18240\/ijo.2023.07.21.","journal-title":"Int J Ophthalmol"},{"issue":"8","key":"2884_CR2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41433-020-0827-y","volume":"34","author":"HY Zeng","year":"2020","unstructured":"Zeng HY, Liu Q, Li XX, Sun YX, Zhang ZJ. One-year efficacy of intravitreal conbercept injection for macular oedema secondary to central retinal vein occlusion in Chinese patients. Eye (Lond). 2020;34(8):1459\u201364. https:\/\/doi.org\/10.1038\/s41433-020-0827-y.","journal-title":"Eye (Lond)"},{"issue":"2","key":"2884_CR3","first-page":"98","volume":"38","author":"H Zhang","year":"2002","unstructured":"Zhang H, Xia Y. Analysis of visual prognosis and correlative factors in retinal vein occlusion. Zhonghua Yan Ke Za Zhi. 2002;38(2):98\u2013102.","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"2","key":"2884_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00417-009-1167-6","volume":"248","author":"T Ach","year":"2010","unstructured":"Ach T, Hoeh AE, Schaal KB, Scheuerle AF, Dithmar S. Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2010;248(2):155\u20139. https:\/\/doi.org\/10.1007\/s00417-009-1167-6.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"2884_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12886-018-0701-x","volume":"18","author":"K Brogan","year":"2018","unstructured":"Brogan K, Precup M, Rodger A, Young D, Gilmour DF. Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab. BMC Ophthalmol. 2018;18(1):37. https:\/\/doi.org\/10.1186\/s12886-018-0701-x.","journal-title":"BMC Ophthalmol"},{"issue":"7","key":"2884_CR6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00417-020-04679-8","volume":"258","author":"YY Koh","year":"2020","unstructured":"Koh YY, Lai CC, Wu WC, Hwang YS, Chen KJ, Wang NK, Chen TL, Huang JC, Liu L, Yeung L. Baseline clinical features predict visual outcome in young patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2020;258(7):1367\u201377. https:\/\/doi.org\/10.1007\/s00417-020-04679-8.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"2884_CR7","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1097\/IAE.0000000000001404","volume":"37","author":"Z Sun","year":"2017","unstructured":"Sun Z, Zhou H, Lin B, Jiao X, Luo Y, Zhang F, Tao S, Wu Q, Ke Z, Liu X. Efficacy and safety of intravitreal conbercept injections in macular edema secondary to retinal vein occlusion. Retina. 2017;37(9):1723\u201330. https:\/\/doi.org\/10.1097\/IAE.0000000000001404.","journal-title":"Retina"},{"issue":"2","key":"2884_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000509171","volume":"64","author":"J Rao","year":"2021","unstructured":"Rao J, Wu N, Qu X, Hu Y, Wu Y, Cheng Y, Yan L, Huang H, Li S, Shi L, Wu X. The role of serum inflammation-based factors in anti-vascular endothelial growth factor treatment for macular edema secondary to retinal vein occlusion and its subtypes. Ophthalmic Res. 2021;64(2):237\u201345. https:\/\/doi.org\/10.1159\/000509171.","journal-title":"Ophthalmic Res"},{"issue":"4","key":"2884_CR9","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1177\/11206721231214145","volume":"34","author":"S Si","year":"2024","unstructured":"Si S, Chen A, Ji Y, Wang J. Poor response to first intravitreal injection for predicting unfavorable outcomes of retinal vein occlusion related macular edema. Eur J Ophthalmol. 2024;34(4):1201\u201310. https:\/\/doi.org\/10.1177\/11206721231214145.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"2884_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bja.2017.11.009","volume":"120","author":"GL Ackland","year":"2018","unstructured":"Ackland GL, Abbott TEF, Pearse RM, Karmali SN, Whittle J, Minto G, POM-HR Study Investigators. Arterial pulse pressure and postoperative morbidity in high-risk surgical patients. Br J Anaesth. 2018;120(1):94\u2013100. https:\/\/doi.org\/10.1016\/j.bja.2017.11.009.","journal-title":"Br J Anaesth"},{"issue":"4","key":"2884_CR11","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s10792-022-02237-1","volume":"42","author":"MF Karada\u011f","year":"2022","unstructured":"Karada\u011f MF. Evaluation of augmentation index and pulse wave velocity measurements in central retinal vein occlusion patients with and without hypertension. Int Ophthalmol. 2022;42(4):1347\u201354. https:\/\/doi.org\/10.1007\/s10792-022-02237-1.","journal-title":"Int Ophthalmol"},{"issue":"8","key":"2884_CR12","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1080\/10641963.2018.1557678","volume":"41","author":"T Kaihara","year":"2019","unstructured":"Kaihara T, Hoshide S, Tomitani N, Kanegae H, Kario K, J-HOP Study Group. Maximum home systolic blood pressure is a marker of carotid atherosclerosis. Clin Exp Hypertens. 2019;41(8):774\u20138. https:\/\/doi.org\/10.1080\/10641963.2018.1557678.","journal-title":"Clin Exp Hypertens"},{"issue":"10","key":"2884_CR13","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00417-014-2617-3","volume":"252","author":"M Mozaffarieh","year":"2014","unstructured":"Mozaffarieh M, B\u00e4rtschi M, Henrich PB, Schoetzau A, Flammer J. Retinal venous pressure in the non-affected eye of patients with retinal vein occlusions. Graefes Arch Clin Exp Ophthalmol. 2014;252(10):1569\u201371. https:\/\/doi.org\/10.1007\/s00417-014-2617-3.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"2884_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.survophthal.2012.05.003","volume":"58","author":"L Quaranta","year":"2013","unstructured":"Quaranta L, Katsanos A, Russo A, Riva I. 24-hour intraocular pressure and ocular perfusion pressure in glaucoma. Surv Ophthalmol. 2013;58(1):26\u201341. https:\/\/doi.org\/10.1016\/j.survophthal.2012.05.003.","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"2884_CR15","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.18240\/ijo.2023.10.13","volume":"16","author":"Y Ye","year":"2023","unstructured":"Ye Y, Deng YM, Huang Z, Wu QW, Hui YN, Song YP. Long-term outcomes of anti-VEGF treatment with 5+PRN regimen for macular edema due to central retinal vein occlusion. Int J Ophthalmol. 2023;16(10):1642\u201350. https:\/\/doi.org\/10.18240\/ijo.2023.10.13.","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"2884_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.18240\/ijo.2022.04.14","volume":"15","author":"T Zhao","year":"2022","unstructured":"Zhao T, Chen Y, Zhang HS, Chen Y, Wang ZJ. Efficacy of conbercept after switching from bevacizumab\/ranibizumab in eyes of macular edema secondary to central retinal vein occlusion. Int J Ophthalmol. 2022;15(4):609\u201314. https:\/\/doi.org\/10.18240\/ijo.2022.04.14.","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"2884_CR17","doi-asserted-by":"publisher","first-page":"010427","DOI":"10.7189\/jogh.09.010427","volume":"9","author":"P Song","year":"2019","unstructured":"Song P, Xu Y, Zha M, Zhang Y, Rudan I. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019;9(1):010427. https:\/\/doi.org\/10.7189\/jogh.09.010427.","journal-title":"J Glob Health"},{"issue":"1","key":"2884_CR18","doi-asserted-by":"publisher","first-page":"19667","DOI":"10.1038\/s41598-020-76840-6","volume":"10","author":"D Nagasato","year":"2020","unstructured":"Nagasato D, Muraoka Y, Osaka R, Iida-Miwa Y, Mitamura Y, Tabuchi H, Kadomoto S, Murakami T, Ooto S, Suzuma K, Tsujikawa A. Factors associated with extremely poor visual outcomes in patients with central retinal vein occlusion. Sci Rep. 2020;10(1):19667. https:\/\/doi.org\/10.1038\/s41598-020-76840-6.","journal-title":"Sci Rep"},{"issue":"11","key":"2884_CR19","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1007\/s10792-022-02344-z","volume":"42","author":"I Chatziralli","year":"2022","unstructured":"Chatziralli I, Kazantzis D, Kroupis C, Machairoudia G, Dimitriou E, Theodossiadis G, Theodossiadis P, Sergentanis TN. The impact of laboratory findings and optical coherence tomography biomarkers on response to intravitreal anti-VEGF treatment in patients with retinal vein occlusion. Int Ophthalmol. 2022;42(11):3449\u201357. https:\/\/doi.org\/10.1007\/s10792-022-02344-z.","journal-title":"Int Ophthalmol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02884-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02884-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02884-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T02:39:06Z","timestamp":1751942346000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02884-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2884"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02884-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Weihai Central Hospital (approval No. LL-2025-067) and conducted in accordance with the tenets of the Declaration of Helsinki. The Board waived the requirement for written consent because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"594"}}